Acuta Capital Partners, LLC Glaukos Corp Put Options Transaction History

Acuta Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2018 Aug 15, 2018	SELL	$27.62 - $44.51 $552,400 - $890,200	-20,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$26.05 - $34.5 $286,550 - $379,500	-11,000 Reduced 35.48%	20,000 $617,000
Q4 2017 Feb 14, 2018	BUY	$24.5 - $36.01 $24,500 - $36,010	1,000 Added 3.33%	31,000 $795,000
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $937,800 - $1.26 Million	30,000	30,000 $990,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.